GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

On Thursday, GSK plc (NYSE:GSK) released headline results from a planned interim analysis of the DREAMM-7 head-to-head phase ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

GSK plc (GSK, GSK.L), on Thursday, announced positive headline results from a planned interim analysis of the DREAMM-7 head-to-head ...

Of the most senior full time jobs on the career ladder to chief executive, such as divisional or regional heads, only 21% are ...

Major companies like pharma giant GlaxoSmithKline (GSK) have established their largest ... holiday and it’s great to see key players from our ecosystem and across Europe hosting a stellar line up of ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...

Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.

The European stock markets closed higher in Thursday trading as The Stoxx Europe rose 1.08%, Germany's DAX climbed 1.26%, the FTSE in London was up 0.51%, France's CAC advanced 1.32%, and the Swiss ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...